Alpha 2.0
Login Register
» Articles » PMID: 24273023

Bisphosphonates Beyond Their Anti-osteoclastic Properties

Overview
Journal Rheumatology (Oxford)
Publisher Oxford University Press
Specialty Rheumatology
Date 2013 Nov 26
PMID 24273023
Citations 10
Authors
Massimo Varenna
Affiliations
Soon will be listed here.
Citing Articles

Osteoclast in CRPS: an alleged guilty fully acquitted.

Varenna M, Zucchi F, Di Taranto R, Orsini F, Crotti C Osteoporos Int. 2025; .

PMID: 39915338 DOI: 10.1007/s00198-025-07415-2.

Bone Turnover Markers and Wnt Signaling Modulators in Early Complex Regional Pain Syndrome. A Pre-specified Observational Study.

Varenna M, Orsini F, Di Taranto R, Zucchi F, Adami G, Gatti D Calcif Tissue Int. 2024; 115(3):251-259.

PMID: 38951180 DOI: 10.1007/s00223-024-01251-y.

Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study.

Varenna M, Gatti D, Zucchi F, Crotti C, Braga V, Iolascon G Ther Adv Musculoskelet Dis. 2022; 14:1759720X221142274.

PMID: 36569491 PMC: 9772942. DOI: 10.1177/1759720X221142274.

In vitro evidence for the involvement of HS pathway in the effect of clodronate during inflammatory response.

Montanaro R, DAddona A, Izzo A, Ruosi C, Brancaleone V Sci Rep. 2021; 11(1):14811.

PMID: 34285296 PMC: 8292495. DOI: 10.1038/s41598-021-94228-y.

Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study.

Varenna M, Braga V, Gatti D, Iolascon G, Frediani B, Zucchi F Ther Adv Musculoskelet Dis. 2021; 13:1759720X211014020.

PMID: 34178124 PMC: 8202309. DOI: 10.1177/1759720X211014020.